United States · Bill · HR
H.R. 2503 (110th)
FDA Scientific Fairness for Women Act
Introduced
24 May 2007
Last action
24 May 2007 · Introduced
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. DeLauro, Rosa L. [D-CT-3], Rep. Solis, Hilda L. [D-CA-32], Rep. Farr, Sam [D-CA-20], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Wexler, Robert [D-FL-19], Rep. Napolitano, Grace F. [D-CA-32], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Sutton, Betty [D-OH-13], Rep. Rush, Bobby L. [D-IL-1], Sen. Baldwin, Tammy [D-WI], Rep. Davis, Susan A. [D-CA-53], Rep. Kilpatrick, Carolyn C. [D-MI-13], Rep. Capps, Lois [D-CA-24], Rep. Holt, Rush [D-NJ-12], Rep. Wynn, Albert Russell [D-MD-4], Rep. Engel, Eliot L. [D-NY-16], Rep. Abercrombie, Neil [D-HI-1], Rep. Boucher, Rick [D-VA-9], Rep. Rothman, Steven R. [D-NJ-9], Rep. Sestak, Joe [D-PA-7], Rep. DeGette, Diana [D-CO-1]
Subjects
Healthcare
Source updated
14 August 2025
Summary
FDA Scientific Fairness for Women Act - Amends the Federal Food, Drug, and Cosmetic Act to establish the Office of Women's Health within the Office of the Commissioner of the Food and Drug Administration (FDA). Deems a breast implant to be a class III medical device. Requires premarket approval of breast implants irrespective of whether the implant has been cleared for commercial distribution in interstate commerce before the date of enactment of this Act. Prohibits the Secretary of Health and Human Services from finding that a reasonable assurance of safety has been shown for an application for premarket approval for a a breast implant unless the applicant involved has demonstrated its safety for the life of the implant. Deems an already approved breast implant to be unsafe under the conditions of use prescribed, recommended, or suggested in the labeling. Requires the Secretary to: (1) issue appropriate, voluntary guidance for clinical care, removal, and replacement for breast implants; (2) require such guidance to be clearly expressed in the labeling and all marketing materials; and (3) require dissemination of such guidance to patients who have already received the implant. Requires the Breast Implant Advisory Panel of the General and Plastic Surgery Advisory Committee to review the results and quality of the research on saline breast implants and silicone gel implants. Requires the Secretary to study the ionization and levels of platinum in silicone breast implants. Requires the Secretary, acting through the Commissioner of Food and Drugs, to convene a scientific workshop to review and evaluate current scientific data on the use of emergency contraception by females of childbearing potential under the age of 18.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
24 May 2007
Referred
Referred to the Subcommittee on Health.
Source: Committee
24 May 2007
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
24 May 2007
Introduced
Introduced in House
Source: IntroReferral
24 May 2007
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 24 May 2007 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 24 May 2007
Introduced in House (PDF)
Introduced in House · EN · 24 May 2007
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 24 May 2007
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. DeLauro, Rosa L. [D-CT-3] · D · Sponsor
- Rep. Solis, Hilda L. [D-CA-32] · D · Sponsor
- Rep. Farr, Sam [D-CA-20] · D · Sponsor
- Rep. Woolsey, Lynn C. [D-CA-6] · D · Sponsor
- Rep. Grijalva, Raúl M. [D-AZ-7] · D · Sponsor
- Rep. Wexler, Robert [D-FL-19] · D · Sponsor
- Rep. Napolitano, Grace F. [D-CA-32] · D · Sponsor
- Rep. Schakowsky, Janice D. [D-IL-9] · D · Sponsor
- Rep. Sutton, Betty [D-OH-13] · D · Sponsor
- Rep. Rush, Bobby L. [D-IL-1] · D · Sponsor
- Sen. Baldwin, Tammy [D-WI] · D · Cosponsor
- Rep. Davis, Susan A. [D-CA-53] · D · Cosponsor
- Rep. Kilpatrick, Carolyn C. [D-MI-13] · D · Cosponsor
- Rep. Capps, Lois [D-CA-24] · D · Cosponsor
- Rep. Holt, Rush [D-NJ-12] · D · Cosponsor
- Rep. Wynn, Albert Russell [D-MD-4] · D · Cosponsor
- Rep. Engel, Eliot L. [D-NY-16] · D · Cosponsor
- Rep. Abercrombie, Neil [D-HI-1] · D · Cosponsor
- Rep. Boucher, Rick [D-VA-9] · D · Cosponsor
- Rep. Rothman, Steven R. [D-NJ-9] · D · Cosponsor
- Rep. Sestak, Joe [D-PA-7] · D · Cosponsor
- Rep. DeGette, Diana [D-CO-1] · D · Cosponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/110th-congress/house-bill/2503
- Open data entity: https://api.congress.gov/v3/bill/110/hr/2503
- us · 110-hr-2503 · source updated 14 August 2025